Apellis Pharmaceuticals, Inc. (APLS)
USD 18.53
(-7.21%)
USD 18.53
(-7.21%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -528.62 Million USD | 18.94% |
| 2022 | -652.17 Million USD | 12.62% |
| 2021 | -746.35 Million USD | -116.41% |
| 2020 | -344.87 Million USD | -11.32% |
| 2019 | -309.81 Million USD | -142.99% |
| 2018 | -127.5 Million USD | -149.97% |
| 2017 | -51 Million USD | -88.04% |
| 2016 | -27.12 Million USD | 41.69% |
| 2015 | -46.51 Million USD | -331.16% |
| 2014 | -10.78 Million USD | -172.33% |
| 2013 | -3.96 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -66.42 Million USD | 25.01% |
| 2024 Q2 | -37.65 Million USD | 43.31% |
| 2024 Q3 | -57.44 Million USD | -52.55% |
| 2023 Q4 | -88.57 Million USD | 36.84% |
| 2023 FY | -528.62 Million USD | 18.94% |
| 2023 Q2 | -122.03 Million USD | 31.35% |
| 2023 Q3 | -140.23 Million USD | -14.91% |
| 2023 Q1 | -177.77 Million USD | -7.1% |
| 2022 Q3 | -191.26 Million USD | -22.63% |
| 2022 FY | -652.17 Million USD | 12.62% |
| 2022 Q2 | -155.97 Million USD | -12.27% |
| 2022 Q1 | -138.93 Million USD | 6.08% |
| 2022 Q4 | -165.99 Million USD | 13.22% |
| 2021 Q4 | -147.93 Million USD | 24.36% |
| 2021 Q1 | -183.65 Million USD | -334.66% |
| 2021 Q2 | -219.19 Million USD | -19.35% |
| 2021 Q3 | -195.57 Million USD | 10.78% |
| 2021 FY | -746.35 Million USD | -116.41% |
| 2020 FY | -344.87 Million USD | -11.32% |
| 2020 Q3 | -135.7 Million USD | -14.4% |
| 2020 Q2 | -118.61 Million USD | 29.74% |
| 2020 Q1 | -168.82 Million USD | -49.11% |
| 2020 Q4 | 78.26 Million USD | 157.68% |
| 2019 Q3 | -69.82 Million USD | 1.78% |
| 2019 Q2 | -71.09 Million USD | -40.57% |
| 2019 FY | -309.81 Million USD | -142.99% |
| 2019 Q1 | -50.57 Million USD | -38.71% |
| 2019 Q4 | -113.21 Million USD | -62.15% |
| 2018 FY | -127.5 Million USD | -149.97% |
| 2018 Q4 | -36.45 Million USD | -1.35% |
| 2018 Q3 | -35.97 Million USD | -7.91% |
| 2018 Q2 | -33.33 Million USD | -53.36% |
| 2018 Q1 | -21.73 Million USD | -19.06% |
| 2017 Q2 | -12.12 Million USD | -33.98% |
| 2017 FY | -51 Million USD | -88.04% |
| 2017 Q4 | -18.25 Million USD | -57.74% |
| 2017 Q3 | -11.57 Million USD | 4.56% |
| 2017 Q1 | -9.05 Million USD | -36.72% |
| 2016 Q3 | -7.21 Million USD | -8.48% |
| 2016 Q4 | -6.62 Million USD | 8.19% |
| 2016 FY | -27.12 Million USD | 41.69% |
| 2016 Q2 | -6.64 Million USD | 0.0% |
| 2016 Q1 | -6.64 Million USD | 19.1% |
| 2015 Q2 | -3.55 Million USD | 0.0% |
| 2015 Q4 | -8.21 Million USD | 73.66% |
| 2015 Q3 | -31.18 Million USD | -777.25% |
| 2015 Q1 | -3.55 Million USD | -32.22% |
| 2015 FY | -46.51 Million USD | -331.16% |
| 2014 Q3 | -2.46 Million USD | 12.25% |
| 2014 Q2 | -2.81 Million USD | 0.0% |
| 2014 Q4 | -2.68 Million USD | -8.87% |
| 2014 FY | -10.78 Million USD | -172.33% |
| 2014 Q1 | -2.81 Million USD | 0.0% |
| 2013 FY | -3.96 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -261.09% |
| Alkermes plc | 355.75 Million USD | 248.592% |
| Agenus Inc. | -245.76 Million USD | -115.098% |
| Aptorum Group Limited | -2.82 Million USD | -18614.834% |
| Ardelyx, Inc. | -66.06 Million USD | -700.139% |
| Dyadic International, Inc. | -6.79 Million USD | -7679.134% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -56377.35% |
| Lantern Pharma Inc. | -15.96 Million USD | -3211.887% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2678.03% |
| Novavax, Inc. | -545.06 Million USD | 3.015% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -806.846% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -616.395% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2750.347% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -5193.691% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -796.243% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -41.484% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2071.912% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1315.715% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -221.21% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -620.722% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2505.234% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -749.133% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1527.299% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -298.986% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -20.077% |
| AlloVir, Inc. | -190.41 Million USD | -177.615% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -157.522% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1757.964% |
| Bicycle Therapeutics plc | -180.66 Million USD | -192.603% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -195.235% |
| ChromaDex Corporation | -4.93 Million USD | -10605.306% |
| Chimerix, Inc. | -82.09 Million USD | -543.922% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1085.176% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -417.907% |
| CRISPR Therapeutics AG | -153.61 Million USD | -244.136% |
| Precision BioSciences, Inc. | -61.31 Million USD | -762.095% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -228.487% |
| Fortress Biotech, Inc. | -60.63 Million USD | -771.791% |
| Fortress Biotech, Inc. | -60.63 Million USD | -771.791% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -547.987% |
| ImmuCell Corporation | -5.77 Million USD | -9054.369% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -367.974% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3326.853% |
| Incyte Corporation | 597.59 Million USD | 188.459% |
| Innoviva, Inc. | 179.72 Million USD | 394.136% |
| IO Biotech, Inc. | -86.08 Million USD | -514.091% |
| Jaguar Health, Inc. | -41.3 Million USD | -1179.971% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -245.527% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1113.591% |
| ContextLogic Inc. | -317 Million USD | -66.76% |
| MiMedx Group, Inc. | 67.43 Million USD | 883.861% |
| MEI Pharma, Inc. | 17.77 Million USD | 3073.495% |
| NextCure, Inc. | -62.72 Million USD | -742.798% |
| Onconetix, Inc. | -37.4 Million USD | -1313.078% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1239.011% |
| Opthea Limited | -220.24 Million USD | -140.021% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -933.303% |
| Vaxcyte, Inc. | -402.26 Million USD | -31.413% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1131.022% |
| Precigen, Inc. | -95.9 Million USD | -451.205% |
| Pharming Group N.V. | -10.54 Million USD | -4911.642% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -162.227% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2053.885% |
| PureTech Health plc | -65.69 Million USD | -704.646% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2006.843% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -149.094% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2071.912% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -105.029% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1840.774% |
| Acelyrin, Inc. | -381.64 Million USD | -38.514% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4214530.195% |
| Summit Therapeutics Inc. | -614.92 Million USD | 14.034% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1450.183% |
| Senti Biosciences, Inc. | -92.91 Million USD | -468.913% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -404.903% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1056.634% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1404.348% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -3944.014% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -7807.674% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1700.381% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6118.421% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -819.145% |
| Seer, Inc. | -86.27 Million USD | -512.71% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -689.056% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -703.814% |
| ESSA Pharma Inc. | -26.58 Million USD | -1888.643% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1332.619% |
| GT Biopharma, Inc. | -7.59 Million USD | -6858.378% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -119.02% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -918.061% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 840.272% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -871.35% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -976.197% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -5214.048% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 7.719% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -14633.222% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -935.348% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -115.244% |
| Aptose Biosciences Inc. | -51.2 Million USD | -932.335% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -437.781% |
| Soligenix, Inc. | -6.14 Million USD | -8508.553% |
| Century Therapeutics, Inc. | -136.67 Million USD | -286.783% |
| Kura Oncology, Inc. | -152.63 Million USD | -246.344% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -492.513% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4916.398% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 93584.712% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -92804.745% |
| Autolus Therapeutics plc | -208.38 Million USD | -153.681% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -635.247% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -646.702% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2339.671% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -134.685% |
| GRI Bio, Inc. | -13.03 Million USD | -3954.829% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -12685.537% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -326.024% |
| IGM Biosciences, Inc. | -246.41 Million USD | -114.527% |
| INmune Bio, Inc. | -30 Million USD | -1661.624% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -378.141% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1152.857% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3211.861% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3246.81% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -785.697% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -422.53% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -91.444% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -122.213% |
| Verastem, Inc. | -87.36 Million USD | -505.066% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -875.544% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -227.657% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -353.143% |
| Histogen Inc. | -10.62 Million USD | -4877.196% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3600.126% |
| Surrozen, Inc. | -43.04 Million USD | -1128.168% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3503.217% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10291.684% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -910.009% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1992.499% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1862.388% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -6225.506% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -249.888% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -980.463% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1678.395% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -4974.323% |
| Apollomics, Inc. | -172.6 Million USD | -206.272% |
| Amarin Corporation plc | -59.11 Million USD | -794.282% |
| Mesoblast Limited | -87.95 Million USD | -501.014% |
| Turnstone Biologics Corp. | -55.2 Million USD | -857.659% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -259.704% |
| Synaptogenix, Inc. | -6.03 Million USD | -8654.287% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3161.525% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -577.554% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10932.699% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -6191.546% |
| Exelixis, Inc. | 207.76 Million USD | 354.436% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1229.547% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -267.235% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4242.974% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -6681.899% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1619.171% |
| Gritstone bio, Inc. | -138.49 Million USD | -281.708% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -720.023% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -13115.865% |
| Avid Bioservices, Inc. | -140.75 Million USD | -275.571% |
| Insmed Incorporated | -749.56 Million USD | 29.476% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3380.218% |
| MediWound Ltd. | -6.71 Million USD | -7771.173% |
| OmniAb, Inc. | -50.61 Million USD | -944.327% |
| Alector, Inc. | -130.39 Million USD | -305.418% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -364.834% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -919.592% |
| Zai Lab Limited | -334.62 Million USD | -57.979% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -63.164% |
| Aura Biosciences, Inc. | -76.4 Million USD | -591.849% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -125.301% |
| Immunic, Inc. | -93.61 Million USD | -464.701% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -289.003% |
| Veracyte, Inc. | -74.4 Million USD | -610.483% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -6787.168% |
| FibroGen, Inc. | -284.23 Million USD | -85.985% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1915.203% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7449.79% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2706.97% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 227.432% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2243.729% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1172.899% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4271.622% |
| Galecto, Inc. | -38.34 Million USD | -1278.466% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2702.014% |
| Fortrea Holdings Inc. | -3.4 Million USD | -15447.882% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -317.413% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2936.173% |
| XBiotech Inc. | -24.55 Million USD | -2052.657% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -720.023% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -743.376% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -437.082% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2367.112% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -857.781% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 12.86% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -674.49% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -928392.641% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -133.35% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2273.987% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -140.603% |
| NexImmune, Inc. | -32.34 Million USD | -1534.373% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -9899.444% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3663.576% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 113.371% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2082.519% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4453.281% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -352.6% |
| Ainos, Inc. | -13.77 Million USD | -3738.83% |
| Pluri Inc. | -20.88 Million USD | -2430.774% |
| Prothena Corporation plc | -147.02 Million USD | -259.542% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -364.234% |
| Celularity Inc. | -196.29 Million USD | -169.303% |
| Rallybio Corporation | -74.56 Million USD | -608.959% |
| Cue Biopharma, Inc. | -50.73 Million USD | -941.981% |
| MeiraGTx Holdings plc | -84.02 Million USD | -529.117% |
| Omeros Corporation | -117.81 Million USD | -348.701% |
| Humacyte, Inc. | -110.77 Million USD | -377.204% |
| Immunocore Holdings plc | -55.28 Million USD | -856.152% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2839.435% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2205.299% |
| Blueprint Medicines Corporation | -506.98 Million USD | -4.269% |
| CalciMedica, Inc. | -34.35 Million USD | -1438.633% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -681.127% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -273.84% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -218.856% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -86.626% |
| Pulmatrix, Inc. | -14.12 Million USD | -3643.559% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1401.997% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -539.691% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -9.858% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -404.075% |
| Cytokinetics, Incorporated | -526.24 Million USD | -0.453% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1365.765% |
| Nutriband Inc. | -5.48 Million USD | -9537.151% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1207.838% |
| Vor Biopharma Inc. | -117.86 Million USD | -348.511% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 112.155% |
| Evogene Ltd. | -23.87 Million USD | -2113.778% |
| ProKidney Corp. | -35.46 Million USD | -1390.436% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -341.395% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -6638.072% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 17.813% |
| CorMedix Inc. | -46.33 Million USD | -1040.779% |
| BioLineRx Ltd. | -60.61 Million USD | -772.122% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -419.567% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1187.264% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1214.21% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -555.458% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -599.975% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -80.919% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1796.355% |
| MediciNova, Inc. | -8.57 Million USD | -6067.264% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -328.813% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6210.594% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1935.787% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -120.963% |
| Biomea Fusion, Inc. | -117.25 Million USD | -350.836% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 15.636% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1694.027% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -245.143% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -152.497% |
| Absci Corporation | -110.56 Million USD | -378.111% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1653.327% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -424.24% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -124.055% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3853.394% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -173.954% |
| Allakos Inc. | -185.7 Million USD | -184.666% |
| Imunon, Inc. | -19.51 Million USD | -2608.832% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -443.102% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 598.048% |
| BioAtla, Inc. | -123.46 Million USD | -328.171% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4242.974% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3187.897% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -61.529% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1330.696% |
| XOMA Corporation | -40.83 Million USD | -1194.673% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -418.924% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -346.051% |
| aTyr Pharma, Inc. | -50.38 Million USD | -949.094% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -502.913% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -248.334% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -122.361% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1405.248% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -6432.772% |
| Akari Therapeutics, Plc | -10 Million USD | -5182.054% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -785088.266% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 287.727% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7831.523% |
| UroGen Pharma Ltd. | -102.24 Million USD | -417.026% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -395.002% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -6697.165% |
| Orgenesis Inc. | -55.36 Million USD | -854.874% |
| Entera Bio Ltd. | -8.88 Million USD | -5846.991% |
| GH Research PLC | -35.58 Million USD | -1385.453% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2436.603% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -583.088% |
| Xencor, Inc. | -126.08 Million USD | -319.257% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -13937.967% |
| Replimune Group, Inc. | -215.79 Million USD | -144.969% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2385.727% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 21169.271% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7831.523% |
| Portage Biotech Inc. | -75.33 Million USD | -601.666% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6210.594% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -446.923% |
| OncoCyte Corporation | -27.78 Million USD | -1802.84% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3839.924% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4653.199% |
| Purple Biotech Ltd. | -19.88 Million USD | -2559.095% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -7431.386% |
| scPharmaceuticals Inc. | -54.81 Million USD | -864.474% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2919.672% |
| HilleVax, Inc. | -123.56 Million USD | -327.81% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5130.316% |
| Tharimmune, Inc. | -9.31 Million USD | -5572.526% |
| Genprex, Inc. | -30.86 Million USD | -1612.962% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -124.066% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1656.589% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -29564.871% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -9881.618% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3141733.864% |
| Savara Inc. | -54.69 Million USD | -866.448% |
| Curis, Inc. | -47.41 Million USD | -1014.943% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1652.665% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3322.629% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -9392.333% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1673.027% |
| BeiGene, Ltd. | -881.7 Million USD | 40.045% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2382.521% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -21.143% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -569.531% |
| Erasca, Inc. | -125.04 Million USD | -322.76% |
| bluebird bio, Inc. | -211.91 Million USD | -149.455% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10471.509% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 415.326% |
| DBV Technologies S.A. | -72.72 Million USD | -626.876% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10471.509% |
| Moderna, Inc. | -4.71 Billion USD | 88.786% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1216.403% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -9183.948% |
| Molecular Templates, Inc. | -8.12 Million USD | -6406.992% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -775.386% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -374.536% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -290.558% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1003.17% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -273.776% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -174.74% |
| MacroGenics, Inc. | -9.05 Million USD | -5736.034% |
| RenovoRx, Inc. | -10.23 Million USD | -5066.419% |
| Adicet Bio, Inc. | -142.65 Million USD | -270.556% |
| Prime Medicine, Inc. | -198.13 Million USD | -166.805% |
| Aditxt, Inc. | -32.38 Million USD | -1532.533% |
| Adagene Inc. | -18.94 Million USD | -2690.128% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7129.869% |
| Quantum-Si incorporated | -95.96 Million USD | -450.884% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -344.117% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3526.262% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 499.477% |
| SciSparc Ltd. | -5.12 Million USD | -10220.734% |
| Vericel Corporation | -3.18 Million USD | -16513.074% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -439492.862% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1661.779% |
| Generation Bio Co. | -126.61 Million USD | -317.518% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -625.231% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -541.212% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -101.659% |
| Invivyd, Inc. | -198.64 Million USD | -166.12% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -54.582% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -5985.576% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2417.934% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -5253.737% |
| 2seventy bio, Inc. | -217.57 Million USD | -142.969% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1771.978% |
| Clene Inc. | -49.5 Million USD | -967.849% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2271.854% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -969.361% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1935.787% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -61.135% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1524.403% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2426.708% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -435.093% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -607.157% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -228.739% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 14.053% |
| Evaxion Biotech A/S | -22.12 Million USD | -2289.279% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -554.761% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -164.224% |
| Trevena, Inc. | -40.28 Million USD | -1212.09% |
| Surrozen, Inc. | -43.04 Million USD | -1128.168% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -664.643% |
| Cingulate Inc. | -23.53 Million USD | -2146.141% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -7547.975% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1226.212% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -6755.796% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -485.997% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -762.559% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -788.406% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4321.804% |
| Kronos Bio, Inc. | -112.67 Million USD | -369.17% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -663.946% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -20842962.341% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -515.435% |
| Statera Biopharma, Inc. | -174.4 Million USD | -203.098% |
| ImmunityBio, Inc. | -583.19 Million USD | 9.357% |
| Korro Bio, Inc. | -81.17 Million USD | -551.244% |
| Kineta, Inc. | -14.09 Million USD | -3649.401% |
| BioVie Inc. | -32.12 Million USD | -1545.763% |
| Codexis, Inc. | -76.24 Million USD | -593.374% |
| Celularity Inc. | -196.29 Million USD | -169.303% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -146.413% |
| Celcuity Inc. | -63.77 Million USD | -728.842% |
| Virax Biolabs Group Limited | -6.73 Million USD | -7750.673% |
| Cibus, Inc. | -267.62 Million USD | -97.524% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1210.886% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1376.161% |
| IN8bio, Inc. | -30 Million USD | -1661.682% |
| Kodiak Sciences Inc. | -260.49 Million USD | -102.935% |
| Annexon, Inc. | -134.23 Million USD | -293.802% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -351.183% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -763.376% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1575.843% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -44.321% |
| Eyenovia, Inc. | -27.26 Million USD | -1839.13% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2548.372% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -98708.972% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -591.885% |
| Arcellx, Inc. | -70.69 Million USD | -647.812% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1175.616% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -295.041% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1659.923% |
| Moolec Science SA | -51.78 Million USD | -920.736% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -909.391% |
| Geron Corporation | -184.12 Million USD | -187.1% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1159.418% |
| Royalty Pharma plc | 1.13 Billion USD | 146.582% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -288.823% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -5845.116% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2388.454% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -207.933% |
| Humacyte, Inc. | -110.77 Million USD | -377.204% |
| Structure Therapeutics Inc. | -89.62 Million USD | -489.855% |
| 89bio, Inc. | -142.18 Million USD | -271.778% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -666.572% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -4994.228% |
| Genelux Corporation | -28.29 Million USD | -1768.141% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1718.779% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -198.459% |
| Notable Labs, Ltd. | -11.26 Million USD | -4593.075% |
| Liquidia Corporation | -78.5 Million USD | -573.394% |
| Mustang Bio, Inc. | -51.6 Million USD | -924.433% |
| Immunovant, Inc. | -259.33 Million USD | -103.839% |
| Quantum-Si incorporated | -95.96 Million USD | -450.884% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -625.649% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2627.558% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -450.712% |
| Acasti Pharma Inc. | -12.85 Million USD | -4012.876% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2253.866% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3211.861% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -189.829% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -12189.339% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4139.198% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1692.506% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1255.874% |
| PepGen Inc. | -78.62 Million USD | -572.332% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1675.767% |
| United Therapeutics Corporation | 984.8 Million USD | 153.679% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2274.789% |
| Solid Biosciences Inc. | -96.01 Million USD | -450.568% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10932.699% |
| Immuneering Corporation | -53.47 Million USD | -888.614% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10291.684% |
| Silo Pharma, Inc. | -3.7 Million USD | -14184.606% |
| Belite Bio, Inc | -31.63 Million USD | -1571.181% |
| XOMA Corporation | -40.83 Million USD | -1194.673% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -872.368% |
| Bionomics Limited | -15.49 Billion USD | 96.588% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -529.431% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1713.04% |
| uniQure N.V. | -308.47 Million USD | -71.367% |
| Cassava Sciences, Inc. | -97.21 Million USD | -443.761% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7129.869% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -328.282% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1579.464% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -6345.344% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1718.591% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -98708.972% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1915.203% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3106.721% |
| Altimmune, Inc. | -88.44 Million USD | -497.678% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -248.736% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1713.04% |
| Compugen Ltd. | -18.75 Million USD | -2718.748% |
| Peak Bio, Inc. | -1259.26 USD | -41979157.659% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1047.968% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2330.362% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -56.034% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -537.254% |
| Zura Bio Limited | -60.36 Million USD | -775.792% |
| PolyPid Ltd. | -23.86 Million USD | -2115.076% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3260.208% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -537.254% |
| Instil Bio, Inc. | -156.08 Million USD | -238.675% |
| argenx SE | -295.05 Million USD | -79.164% |
| Immunome, Inc. | -106.8 Million USD | -394.942% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1144.006% |
| Verona Pharma plc | -54.36 Million USD | -872.297% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -429.067% |
| Shattuck Labs, Inc. | -87.29 Million USD | -505.544% |
| CervoMed Inc. | -2.17 Million USD | -24239.729% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -324.086% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3869.871% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1113.702% |
| Moolec Science SA | -51.78 Million USD | -920.736% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3057014.586% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -291.236% |
| AnaptysBio, Inc. | -163.61 Million USD | -223.085% |
| Design Therapeutics, Inc. | -66.86 Million USD | -690.625% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -549.308% |
| NeurAxis, Inc. | -14.62 Million USD | -3514.135% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1295.46% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1453.235% |
| Achilles Therapeutics plc | -69.66 Million USD | -658.814% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -429.067% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2551.743% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 17669.455% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -20842962.341% |
| Nutriband Inc. | -5.48 Million USD | -9537.151% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -424.969% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -987.555% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -585.719% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1456.161% |
| MoonLake Immunotherapeutics | -36 Million USD | -1368.115% |
| Palisade Bio, Inc. | -12.3 Million USD | -4197.789% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1154.933% |
| Beam Therapeutics Inc. | -132.52 Million USD | -298.883% |
| Neurogene Inc. | -36.31 Million USD | -1355.594% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -223.488% |
| AEON Biopharma, Inc. | -52.55 Million USD | -905.838% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -438.608% |
| Sesen Bio, Inc. | -19.88 Million USD | -2558.56% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -638.472% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4124.328% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -19.05% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -373.825% |
| Athira Pharma, Inc. | -117.67 Million USD | -349.239% |
| Vaccinex, Inc. | -20.25 Million USD | -2510.38% |
| HCW Biologics Inc. | -24.99 Million USD | -2014.996% |
| XOMA Corporation | -40.83 Million USD | -1194.673% |
| Nektar Therapeutics | -276.05 Million USD | -91.493% |
| Arvinas, Inc. | -367.3 Million USD | -43.923% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -785088.266% |
| Merus N.V. | -154.93 Million USD | -241.185% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -442.583% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1584.333% |
| Rezolute, Inc. | -68.45 Million USD | -672.182% |
| Clene Inc. | -49.5 Million USD | -967.849% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3327.426% |
| BeyondSpring Inc. | -21.02 Million USD | -2414.163% |
| Synlogic, Inc. | -57.28 Million USD | -822.852% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4341.879% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4782.948% |
| Peak Bio, Inc. | -1259.26 USD | -41979157.659% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1314.654% |
| Krystal Biotech, Inc. | 10.93 Million USD | 4935.602% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -269.414% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -62.603% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -11344.728% |
| MannKind Corporation | -11.93 Million USD | -4328.112% |
| Ikena Oncology, Inc. | -68.16 Million USD | -675.501% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2415.479% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -468.827% |
| Gossamer Bio, Inc. | -179.81 Million USD | -193.981% |
| CohBar, Inc. | -11.96 Million USD | -4319.184% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1949.899% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1653.327% |
| Legend Biotech Corporation | -518.25 Million USD | -2.002% |
| Mural Oncology plc | -207.44 Million USD | -154.826% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -325.918% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2790.3% |
| Disc Medicine, Inc. | -76.42 Million USD | -591.659% |
| Champions Oncology, Inc. | -7.27 Million USD | -7165.366% |
| REGENXBIO Inc. | -263.49 Million USD | -100.622% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4880.913% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1012.784% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1291.731% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -427.768% |
| Vaxart, Inc. | -82.46 Million USD | -541.033% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 158484.243% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1308.078% |
| Cellectis S.A. | -101.05 Million USD | -423.088% |
| Longeveron Inc. | -21.41 Million USD | -2368.725% |
| Repare Therapeutics Inc. | -93.79 Million USD | -463.593% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 1.371% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -642.778% |
| Revolution Medicines, Inc. | -436.36 Million USD | -21.143% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -7944.864% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1614.988% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -662.448% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -716.641% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -5288.115% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 114.605% |
| Denali Therapeutics Inc. | -145.22 Million USD | -264.009% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -439492.862% |
| Veru Inc. | -93.15 Million USD | -467.485% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1855.781% |
| Cingulate Inc. | -23.53 Million USD | -2146.141% |
| Passage Bio, Inc. | -102.06 Million USD | -417.948% |
| Context Therapeutics Inc. | -23.96 Million USD | -2105.906% |
| Exicure, Inc. | -16.91 Million USD | -3025.387% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -179.82% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1299.82% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -8023.584% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -186.243% |
| Nuvalent, Inc. | -126.21 Million USD | -318.818% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4927.057% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -508.465% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1630.71% |
| OmniAb, Inc. | -50.61 Million USD | -944.327% |
| Anew Medical, Inc. | 1.34 Million USD | 39370.35% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3194.659% |
| Lipocine Inc. | -16.35 Million USD | -3132.787% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -696.198% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -730.197% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1152.857% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1002.066% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2565.665% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 2.375% |
| Ocugen, Inc. | -63.07 Million USD | -738.054% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -452.196% |
| Q32 Bio Inc. | -112.96 Million USD | -367.974% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2974.849% |
| Alumis Inc. Common Stock | -154.99 Million USD | -241.066% |
| Equillium, Inc. | -13.33 Million USD | -3864.214% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -775.705% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -6517.913% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2704.21% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -794.736% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -361.575% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2776.425% |
| Dominari Holdings Inc. | -22.88 Million USD | -2210.235% |
| Edesa Biotech, Inc. | -8.37 Million USD | -6212.417% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2510.509% |
| Bio-Techne Corporation | 168.1 Million USD | 414.463% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -50.141% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 510.257% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -333.899% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1293.363% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -369.299% |
| Nkarta, Inc. | -117.5 Million USD | -349.892% |
| BioCardia, Inc. | -11.57 Million USD | -4468.559% |
| Iterum Therapeutics plc | -38.37 Million USD | -1277.676% |